138 related articles for article (PubMed ID: 12601009)
1. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF.
Bitard J; Daburon S; Duplomb L; Blanchard F; Vuisio P; Jacques Y; Godard A; Heath JK; Moreau JF; Taupin JL
J Biol Chem; 2003 May; 278(18):16253-61. PubMed ID: 12601009
[TBL] [Abstract][Full Text] [Related]
2. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
Voisin MB; Bitard J; Daburon S; Moreau JF; Taupin JL
J Biol Chem; 2002 Apr; 277(16):13682-92. PubMed ID: 11834739
[TBL] [Abstract][Full Text] [Related]
3. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
4. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
Heymann D; Godard A; Raher S; Bentouimou N; Blanchard F; Cherel M; Hallet MM; Jacques Y
Cytokine; 1996 Mar; 8(3):197-205. PubMed ID: 8833034
[TBL] [Abstract][Full Text] [Related]
5. Binding of leukemia inhibitory factor (LIF) to mutants of its low affinity receptor, gp190, reveals a LIF binding site outside and interactions between the two cytokine binding domains.
Taupin JL; Miossec V; Pitard V; Blanchard F; Daburon S; Raher S; Jacques Y; Godard A; Moreau JF
J Biol Chem; 1999 May; 274(20):14482-9. PubMed ID: 10318874
[TBL] [Abstract][Full Text] [Related]
6. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
7. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
[TBL] [Abstract][Full Text] [Related]
8. Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.
Blanchard F; Pitard V; Taupin JL; Raher S; Hallet MM; Moreau JF; Godard A; Jacques Y
Int Immunol; 1997 Dec; 9(12):1775-84. PubMed ID: 9466305
[TBL] [Abstract][Full Text] [Related]
9. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor.
Blanchard F; Raher S; Duplomb L; Vusio P; Pitard V; Taupin JL; Moreau JF; Hoflack B; Minvielle S; Jacques Y; Godard A
J Biol Chem; 1998 Aug; 273(33):20886-93. PubMed ID: 9694835
[TBL] [Abstract][Full Text] [Related]
10. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
11. Identification of agonistic and antagonistic antibodies against gp190, the leukemia inhibitory factor receptor, reveals distinct roles for its two cytokine-binding domains.
Taupin JL; Legembre P; Bitard J; Daburon S; Pitard V; Blanchard F; Duplomb L; Godard A; Jacques Y; Moreau JF
J Biol Chem; 2001 Dec; 276(51):47975-81. PubMed ID: 11606572
[TBL] [Abstract][Full Text] [Related]
12. Binding interactions of leukemia inhibitory factor and ciliary neurotrophic factor with the different subunits of their high affinity receptors.
Robledo O; Auguste P; Coupey L; Praloran V; Chevalier S; Pouplard A; Gascan H
J Neurochem; 1996 Apr; 66(4):1391-9. PubMed ID: 8627290
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190.
Pitard V; Taupin JL; Miossec V; Blanchard F; Cransac M; Jollet I; Vernallis A; Hudson K; Godard A; Jacques Y; Moreau JF
J Immunol Methods; 1997 Jul; 205(2):177-90. PubMed ID: 9294600
[TBL] [Abstract][Full Text] [Related]
14. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
15. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
Gearing DP; Comeau MR; Friend DJ; Gimpel SD; Thut CJ; McGourty J; Brasher KK; King JA; Gillis S; Mosley B
Science; 1992 Mar; 255(5050):1434-7. PubMed ID: 1542794
[TBL] [Abstract][Full Text] [Related]
16. The unusual species cross-reactivity of the leukemia inhibitory factor receptor alpha-chain is determined primarily by the immunoglobulin-like domain.
Owczarek CM; Zhang Y; Layton MJ; Metcalf D; Roberts B; Nicola NA
J Biol Chem; 1997 Sep; 272(38):23976-85. PubMed ID: 9295349
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
Ichihara M; Hara T; Kim H; Murate T; Miyajima A
Blood; 1997 Jul; 90(1):165-73. PubMed ID: 9207450
[TBL] [Abstract][Full Text] [Related]
18. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
Ernst M; Novak U; Nicholson SE; Layton JE; Dunn AR
J Biol Chem; 1999 Apr; 274(14):9729-37. PubMed ID: 10092661
[TBL] [Abstract][Full Text] [Related]
19. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of a specific receptor for mouse oncostatin M.
Lindberg RA; Juan TS; Welcher AA; Sun Y; Cupples R; Guthrie B; Fletcher FA
Mol Cell Biol; 1998 Jun; 18(6):3357-67. PubMed ID: 9584176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
